What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide for HR+

(7:8)

Foundation Frontiers: Advanced Breast Cancer - Updates to HR+/HER2- Treatment Landscape

(16:)

Palbociclib Combined With Fulvestrant in Relapsed Metastatic HR+/HER2- Breast Cancer

(2:2)

FDA Approved AKT Inhibitor for Patients With Advanced HR-Positive Breast Cancer

(4:41)

Management of premenopausal HR+/HER2- breast cancer with micro-metastasis

(2:14)

Important considerations in the management of HR+, HER2-negative early breast cancer

(2:5)

Current state of CDK4/6 inhibitors in metastatic HER2-negative breast cancer

(1:25)

Rethinking Breast Cancer: Optimal Trial Design and Exploring Novel Modalities

(54:16)

ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne

(7:15)

Outlook for HR+/HER2- advanced breast cancer treatment

(2:15)

Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding t...

(33:11)

Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer

(30:49)

Optimizing adjuvant therapy: chemotherapy necessity in HR-positive breast cancer

(1:19)

HER2 Positive Breast Cancer: Everything You Must Know

(13:8)

How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers

(21:3)

DESTINY-Breast12: T-DXd in patients with HER2+/HR- breast cancer with brain metastasis

(44)

Identifying drivers of first-line HR+/HER2- metastatic breast cancer treatment choices

(2:24)

Helping to Address Unmet Needs in Metastatic HR+/HER2- Breast Cancer

(34)

Treatments for HR+, HER2-Negative Metastatic Breast Cancer

(3:12)

HER2-positive Breast Cancer - How does it work? A doctor explains with simple images.

(3:11)